The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be further influenced by the extensive pipeline of ...

Co. Ltd. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of diabetes, obesity, Alzheimer’s disease, overweight and nonalcoholic or metabolic ...

Radiance Biopharma Inc. bought its way into the ROR1 antibody-drug conjugate (ADC) space through a potential $1 billion-plus licensing deal, including a $15 million up-front payment, with CSPC ...

CSPC Megalith Biopharmaceutical has entered into a license agreement with Radiance Biopharma for the development and ...

Japanese stocks ended lower amid concerns about borrowing costs and continued U.S. tariffs, with auto and chip stocks leading the declines.

The Hong Kong stock market has alternated between positive and negative finishes through the last seven trading days since the end of ...

Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License agreement with CSPC Megalith Biopharmaceutical Co., Ltd, ...

Gen­uine Biotech files for HKEX list­ing: The drug de­vel­op­er, which has mul­ti­ple lo­ca­tions in Chi­na, Get free access to a limited number of articles, plus choose newsletters to get straight to ...

Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying China’s CSPC Megalith Biopharmaceutical $15 ...

The Hong Kong stock market has alternated between positive and negative finishes through the last six trading days since the end of ...

Around 300 people gathered outside the Colorado Springs City Hall on Monday afternoon to protest President Donald Trump’s ...